Age Control Brightening And Anti-Fatigue Eye Cream

Age Control Brightening And Anti-Fatigue Eye Cream

Brand:
AHAVA
Manufacturer:
Ahava Dead Sea Laboratories, Ltd.
Country of Origin:
Israel
00 votes
Repurchase Rate0%

Quality

Joy

Value for money

Price segment

Description

This awakening eye cream is based on Osmoter™, our signature blend of Dead Sea minerals and the patented 3D™ Complex, proven to smooth the skin’s surface. Enriched with peptides and soothing botanicals, this eye cream significantly brightens dark circles and signs of fatigue, reduces the appearance of fine lines and wrinkles and provides essential hydration to refresh the delicate eye area.

Ingredients

AQUA (MINERAL SPRING WATER), GLYCERIN, 1,2-HEXANEDIOL, BUTYLENE GLYCOL, AGAR, CARRAGEENAN, ALLANTOIN, SUCROSE, ALOE BARBADENSIS LEAF JUICE, OLEA EUROPAEA (OLIVE) FRUIT OIL, CUCUMIS SATIVUS (CUCUMBER) FRUIT EXTRACT, SACCHARIDE HYDROLYSATE, NIACINAMIDE, CAFFEINE, CREATINE, SIMMONDSIA CHINENSIS (JOJOBA) SEED EXTRACT, SODIUM HYALURONATE, ACETYL HEXAPEPTIDE-8, XANTHAN GUM, CERATONIA SILIQUA (CAROB) GUM, PEG-60 HYDROGENATED CASTOR OIL, CARBOMER, ETHYLHEXYLGLYCERIN, DISODIUM EDTA, MARIS AQUA (DEAD SEA WATER/OSMOTER), MICA, HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER, PVP, CAPRYLYL METHICONE, ISODECYL NEOPENTANOATE, ISOHEXADECANE, TITANIUM DIOXIDE (CI 77891), BISABOLOL, PARFUM (FRAGRANCE), SODIUM LACTATE, PHENOXYETHANOL, HYDROGENATED POLYISOBUTENE, PEG-12 DIMETHICONE/PPG-20 CROSSPOLYMER, SILICA, DISODIUM LAURIMINODIPROPIONATE TOCOPHERYL PHOSPHATES, UREA, FARNESOL, ALANINE, GLYCINE, MAGNESIUM ASPARTATE, SODIUM BENZOATE, LECITHIN, AMINOMETHYL PROPANOL, POTASSIUM SORBATE, TIN OXIDE, SODIUM CITRATE, PALMITOYL CARNITINE, CITRIC ACID, TRISODIUM EDTA, TOCOPHEROL, BENZOIC ACID, SODIUM METABISULFITE, DEHYDROACETIC ACID, IRON OXIDE RED (CI 77491), HAMAMELIS VIRGINIANA LEAF WATER

***

Ingredients are subject to change at the manufacturer's discretion. For the most complete and up-to-date list of ingredients, refer to the product packaging.

Comments 0